JD Health International Inc. disclosed that its issued share capital remained unchanged at 3.21 billion ordinary shares as of 24 June 2026, with no treasury shares outstanding.

From 15 May to 24 June 2026, the company executed 20 on-market buybacks totaling 19.94 million shares, all designated for cancellation. This volume represents 0.62 % of the shares outstanding on 20 June 2025, the date when the existing repurchase mandate—authorizing up to 320.01 million shares—was approved.

The most recent transaction occurred on 24 June 2026, when 500,000 shares were repurchased on the Hong Kong Stock Exchange at prices ranging between HKD 33.02 and HKD 33.70, for an aggregate consideration of HKD 16.69 million. The volume-weighted average price for that day was approximately HKD 33.37 per share.

All 19.94 million repurchased shares are pending cancellation; consequently, the share count disclosed does not yet reflect these reductions. In line with Hong Kong listing rules, JD Health is subject to a moratorium on new share issues or treasury-share disposals until 24 July 2026.